Amid the current uncertain macroeconomic environment and lingering recessionary fear, insider trading activity can be a valuable indicator for investors decisions. In this article, I have evaluated two stocks that have recently seen insider buying activity. This post originally appeared at StockNews.com.
While I think the bulls have made major strides in the first quarter, I think it’s too early to say we’re completely out of the woods. So I thought this would be the perfect time to look back at the Q1 of 2023 and review the factors that influence the S&P 500 and what we can learn from this to…
Let’s start with a helpful analogy that will frame our discussion today. And that is to appreciate that the stock market is quite similar to a helium balloon. Meaning that its natural state is to float higher unless it is being held down by a stronger, negative force that pushes it lower. Now if we pull back to the big…
Despite macroeconomic challenges, the biotech industry performed relatively well due to inelastic demand for its products and services. Moreover, government initiatives, technological developments, and the biotech ingredients market, which assists businesses in making correct and up-to-date decisions, are all fueling the biotech industry’s expansion. Given the solid prospects of the industry, these four fundamentally sound biotech stocks could be excellent…
With the Fed’s measures to counter inflation causing the collateral damage of asset price deflation, it could be wise to load up on these three value stocks, available at attractive valuations to capture future upside potential while limiting downside risks. Let’s take a closer look at the featured stocks. This post originally appeared at StockNews.com.
The Fed’s potential higher-than-expected interest rate hikes have fueled concerns among investors about a mild recession. Thus, investors nearing retirement could check out stocks with a strong foundation of stability. Let’s discuss why these three stocks could be solid picks on that front. This post originally appeared at StockNews.com.
The economy started the year on a solid footing. However, January’s blowout jobs report, unexpected consumer strength, and persistent inflation challenge the Fed to keep interest rates higher for longer. Last month, retail sales jumped 3%, overshooting estimates of a 1.9% increase. Such resilience paints a picture that the U.S. economy could defy a deep recession. However, a ‘no pause’ situation from…
Expansion of the U.S. economy for the fourth quarter of last year and moderating inflationary pressures led the Fed to choose a less aggressive stance. Hence, the central bank hiked rates by 0.25 percentage points. This revived investor optimism. However, Fed Chair Jerome Powell has been clear about policymakers’ North Star: Getting inflation down to their 2% target. Signaling further rate hikes,…
Following last year’s abysmal performance, stocks have had an encouraging start to 2023, with the Nasdaq Composite and S&P 500 rising more than 10% and 6%, respectively, last month. Also, stocks rallied on better-than-expected fourth-quarter earnings and cooling inflationary pressures. Investors expect the Federal Reserve to issue smaller interest rate increases this year. Furthermore, Goldman Sachs experts anticipate a 35% risk…
The stock market ended 2022 as the worst year since the 2008 economic meltdown, with the Fed launching four consecutive 75-basis-point rate increases in 2022 before wrapping the year with a slightly lower 50-basis-point rate hike. However, the current market backdrop gives investors a golden opportunity to add quality stocks to their portfolios, trading at attractive valuations. Given the fundamental strength, these…